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SUMMARY 
Lecithin, a major surface active substance of surfactant system of the lung was estimated in 
bronchoalveolar lavage (BAL) fluid in healthy adult male albino rats after administration of 
hydrocortisone or histamine. BAL was perfomed in three groups of animals follo\ving 
intravenous administration of 2.5 mg. of hydrocortisone sodium succinate at 10 minute, 30 
minute and 60 minute intervals respectively. Similarly, BAL fluid was obtained in three 
groups of animals following subcutaneous administration of 0.06mg of histamine 
diphosphate at 10 minute, 30 minute and 60 minute intervals. Lecithin content in BAL fluid 
was estimated by enzymatic method using Boehringer-Mannheim Kits. The results 
obtained from these animals were compared with those from control animals who received 
neither hydrocortisone nor histamine. A highly significant reduction in lecithin levels 
indicating a decrease in surfactant activity was observed within 10 minutes after 
administration of hydrocortisone or histamine. However, a gradual increase in lecithin 
levels was observed by one hour in both cases indicating an acute decrease in pulmonary 
surfactant activity. The effect observed might be due to a sudden inhibition of secretion of 
pulmonary surfactant by Type II cells or a sudden increase in uptake by Type II cells or 
both. Further studies are needed to explore the mechanisms involved. Since there is paucity 
of information on the effect of these substances on surfactant system of lung in adult 
human beingsyfue fi_nd~ngs i~ the prese_n~ study c~early in.dicate a need to assay. lecithin 
content in BAL flutd tn pahents recetvtng corticosteroids, as for example, 1n adult 
respiratory distress syndrome and bronchial asthma, and, also in patients with allergic 
disorders such as pulmonary aspergillosis. 
INTRODUCTION 
During breathing, energy is spent to overcorne tissue resistance, ainvay resistance and 
elastic resistance. Tissue resistance is due to inertia of throcic cage and lungs \vhich has to 
be overcome during expansion of thoracic cage and lungs. Airflow through the narrow 
airways encounters resistance i.e., airway resistance.The recoiling tendency of stretched 
elastic tissue of thorax and lungs constitutes elastic resistance. Grouped under elastic 
resistance also are the surface tension forces of alveolar lining that tend to collapse the 
alveoli. Two-thirds of total energy is spent to overcome elastic resistance even during 
normal breathing. 
The surface tension forces of alveolar lining were discovered as early as in 1929 by Von 
Neergard. However, a problean oriented approach to this phcnornenon started with the 
discovery of increased surface tension forces leading to collapse of lung and respiratory 
distress in hyaline membrane disease by Avery and Mead in 1959(1). The presence of 
surfactant in nonnal lungs to act against the surface tension forces was demonstrated by 
clements and Pattie <2•3>. Soon, it's biochernical cornposition in various species including 
hurnanbeings \vas explored(4·5·6>. The rncthodology for extraction and rneasuretnent of it's 
surface tension lowering activity was refined. 
The importance of puhnonary surfactant secreted by Type II alveolar cells in maintaining 
alveolar patency was first observed in respiratory distress syndrorne in newborn. Hence, 
till recently, the research was focussed on the development of pulmonary surfactant system 
and the factors regulating it's secretion during fetal life. Currently, synthetic and natural 
surfactant are used in the treatn1ent of hyaline mernbrane disese. 1-Iowever, in recent years, 
the research is extended lo identify the other functions of surfactant, as for exantple-it's role 
d . . (? S> D I . I in prevention of pultnonary e erna, Bnn1une suppression etc · . rugs w uc 1 were at one 
time thought to relieve only airway resistance were found to have additional action of 
relieving elastic resistance as well by increasing puhnonary surfactant levels in al veoli<9>. 
The rationale of efficacy of frusernide in refractory cases of puhnonary eden1a was 
attributed to it's ability to increase surfactant concentration in the alveo1i(tO)_ Decreased 
pulmonary surfactant activity was also observed in adult respiratory distress syndrorne(tl). 
The innervation to type II cells being sparse, the regulation of surfactant was found to be 
mainly honnonal. Detailed reports on the effect of various honnones on pulmonary 
surfactant system and the mechanism of action of these agents have been published. 
However, again, most of these studies were conducted on pulmonary surfactant system in 
fetal life. Thyroxine and cortisol were shown to be essential in the development of fetal 
pulmonary surfactant system02>. The effect of glucocorticoids, if any, on surfactant system 
of lung in adults has not been explored despite corticosteroids being frequently used in 
various respiratory and other systemic disorders. There \vere no reports indicating the 
invivo effect of histamine on surfactant system of lung, though histamine is a comon 
mediator in many allergic disorders. The objective of this study is to observe the effect, if 
any, of gluco-corticoid (hydrocortisone) and histamine on surfactant system of lung in 
adult male rats. 
MATERIALS AND METHODS 
Healthy adult male albino rats of wistar strain weighing between 200 - 220 gm were used 
for the study. The animals were maintained in cages with free access to air, food and water. 
Broncho-alveolar lavage (BAL) is a standard procedure to assay various components of 
f (lJ) Le . h' . h . . pulmonary sur actant system . ctt tn ts t e maJor surface acttve phospholipid of 
pulmonary surfactant system. Thus, assay of Iechitin in BAL fluid was employed in the 
present study to observe the effect of hydrocortisone and histamine on surfactant system of 
I ung in adult rats. 
Broncho alveolar lavage: 
The control group of animals were given pentobarbitone sodium intraperitoneally at a dose 
of 40 mg/kg. The anaesthetised rats were incised from xi phi sternum to chin. The thorax 
was opened and lungs along with trachea were isolated. The trachea \Vas cannulated and 
alveoli were rinsed with normal saline via the airway. Each time 10 ml of normal saline was 
introduced via the trachea, and, the fluid was retained in the lungs for one minute. Then, it 
was rinsed back and forth, and aspirated. The procedure was repeated till a volume of 15 
ml was extracted for each animal. 
Lungs which had abnormal appearence, as for example, haemorhagic spots or patches were 
not subjected to lavage. Samples from lungs which showed leakage of fluid during lavage, 
and lavage fluid which was contaminated with blood or not clear \Vas not used for 
estimation of lecithin. Further, samples collected with less than 70% of retrieval of instilled 
saline were also not used for determination of lecithin content. A total of eight samples 
which had none of the above defects were taken as control samples for assay of lecithin. 
Assay of Lecithin: 
Assay of Ieci thin was perf onned by enzymatic method using Boehringer - Mannheim kits. 
In brief, the steps are: 
1. Hydrolysis of lecithin 
Lechitin was hydrolyzed by the enzyme phospholipasec and alkaline phosphatase at 
ph 8.0. 
phospholopase c 
Lecithin+ H20 --------------------> 1, 2 diglyceride + phosphorylcholine 
phosphorylcholine is hydrolyzed by alkaline phosphatase to choline and inorganic 
phosphate. 
alkaline phosphatase 
Phosphoryl choline + H20--------------------> choline + _P04 3-
2. Determination of the hydrolyzed lecithin. 
After inactivation of the alkaline phosphatase by heating the solution in a boiling 
water bath, choline was phosphorylated in the presence of ATP to 
phosphorylcholine by enzyme choline kinase 
choline Kinase 
Choline+ A.T.P ------------------> phosphorylcholine + ADP. 
The ADP formed was reconverted by pyruvate kinase with phosphoenolpyruvate 
in to A TP with the fonnation of pyruvate. 
pyruvate kinase 
ADP +Phosphoenolpyruvate ------------------------>ATP +pyruvate 
In the presence of lactate deh¥dro~enase (~DH), pyruvate. \Vas ~edu~ed to lactate by 
reduced Nicotinamide - ademne dtnucleottde (NADH) wtth ox1datton of NADH to 
NAD. 
LDH 
Pyruvate+ NADH -------->Lactate+ NAD + 
The amount of NADH oxidised in the above reaction is stoichiometric with the 
amount of lecithin. NADH is determined by means of it's absorbance at 340 nm. 
To observe the effect of hydrocortisone on surfactant system of lung in adult rats, BAL 
was performed in three groups of animals (8 in each group) following intravenous 
administration of 2.5 mg of hydrocortisone sodium succinate (sigma chemical company) at 
10 minute, 30 minute and 60 minute intervals respectively. The internal jugular vein was 
cannulated under anaesthesia and hydrocortisone was injected into jugular vein of each 
animal. Later, lecithin content in BAL fluid was performed as in control group. 
To observe the effect of histamine on surfactant system of lung in adult rats, BAL was 
performed in three groups of animals (8 in each group) following subcutanesus 
administration of 0.06 ng of histamine diphosphasle (sigma chemical company) at 10 min, 
30 min and 60 min intervals respectively. The dose of histamine administered did not 
produce any untoward effects in the pilot experiments. Later, lecithin content was 
estimated as in control group. 
Statistical analysis of the results obtained was done using student's unpaired 't' test. 
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A highly significant reduction in lecithin content in broncho-alveolar lavage fluid (BAL) 
.:.~> was observed within 10 minutes of administration of hydrocortisone or histamine. 
<·. However, by one hour, there was a gradual increase in lecithin content in both cases. Thus, 
.. ;there is an acute effect of decrease in pulmonary surfactant activity with both these agents. 
· The lecithin levels increased to near normal levels by one hour after administration of 
. , histamine. However, with hydrocortisone, though there is a gradual increase in levels of 
·::·~::·lecithin at hour, they were still significantly lower compared to control animals. The 
_: difference in lecithin levels at 1 hour may be a reflection of plasma half Jives of these 
-· .. -·compounds. Half life of hydrocortisone is about 90 minutes, whereas that of histamine is 
.;.,l';e;,. 
~·.·. inuch shorter. 
>~~~'f•r .· 
Mechanism of decreased lecithin levels following administration of these compounds can 
· not be ascertained from this study. Type II alveolar cells constantly secrete pulmonary 
.::;~?.·surfactant in to alveoli. Reuptake of this substance from the alveoli by the same cells 
.:~~~~homeostasis: of this surface active material in the alveoli< 14>. Thus, the 
:· ~~;~, ~inistered· hydrocortisone or histamine might have inhibited the secretion or stimulated '··~'f't,~,.%'~ ·'" .- •.. 
. :~~:/{.~.~ebptake or both. Some of the surfactant associated proteins inhibit secretion and some ·,.;~~~teuptake {1S,l6). The effects observed in this study could also be due to secretion of 
•'c• . .t"· ,., .• . 
. _-.;,]L~hese: proteins .. Further studies may help identification of the mechanisms involved in the 
/fi ~uction of lecithin content :~~i'· .. ~:-1\;.- ... - . 
. ::.~~:r.~ ;.~c . . . . -
.'~.,~ithin constitutes 60- 70% of the surface active materials found in the pulmonary 
.;:··:~~~factant system. These surface active materials reduce surface tension forces of alveolar 
··;:~·.iining and prevent collapsing tendency. Reduction in pulmonary surfactant activity leads to 
·,·- .. increased work of breathing and respiratory distress. The dose of hydrocortisone employed 
... :_in this study was equivalent to therapeutic doses employed in patients with status 
·.· .. asthmaticus. Biological half life of hydrocostisone being 8- 12 hours, 6 hrly injeetions can 
~:·:·-:.· l~d to a cumulative effect even when the dose is in minimum range. Clinical improvement 
.~}~~'is delayed in cases of status asthmaticus even with intravenous administration of 
.:~;/" glucocorticoids. Decreased lecithin levels in alveoli can lead to undesirable effect of 
<-~.increasing resistance to breathing. This may also be a factor responsible for the delayed 
·::~£;the_ · rapeutic response seen in those patients. 
'#i:.ilf:·:'J, .':~::tr-: .. , -
....... _-:_. 
_: .... · 
High doses of corticosteroids are employed in the management of adult respiratory distres 
syndrome (ARDS). Some investigators observed no beneficial effect whereas some others 
reported an increase in mortility with the use of corticosteroids in some cases of ARDS 
<17• 18>. The decreased lecithin content in alveoli may precipitate or worsen any existing 
lung pathology in ARDS. The present study is in experimental animals and it may not be 
possible to extrapolate data from experimental animals to human beings. However, the 
findings indicate a need to study the effect of hydrocortisone on surfactant system of lung 
. in adult human beings. Estimation of lecithin content in BAL fluid in asthmatics, ARDS 
and in other interstitial lung diseases in whom corticosteroids are frequently used may 
provide a clue in this aspect 
Histamine was reported to cause stimulation of type II cells invitro 09>. However, in the 
present study a decreased pulmonary surfactant activity was observed following histamine 
administration. This is not surprising since the invitro and invivo effects may be different in 
view of the complexity of responses in the whole animal. Decreased lecithin levels in 
alveoli lead to increased resistance to breathing. It is possible that such reduction in lecithin 
levels may be one of the factors responsible for the respiratory disability in allergic 
pulmonary diseases like bronchial asthma and pulmonary aspergillosis. Assay of lecithin in 
··. BAL fluid in these patients may elucidate the effect of histamine on surfactant system of 
lung in adult human beings . 
. ·~ 
~ ·~!.> . 
. ,. 
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